| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |